Department B of Surgery, Charles Nicolle Hospital, University Tunis El Manar, Tunis, Tunisia.
Tunis Med. 2024 Oct 5;102(10):702-707. doi: 10.62438/tunismed.v102i10.5177.
To describe the epidemiological and clinical data of impaired functional outcome secondary to anterior resection of the rectum and to identify the predictive factors of major low anterior resection syndrome (LARS) Methods: This retrospective study considered patients operated on for rectal tumors in surgical department in our hospital, between January 1st,2009 and December 31st, 2021. The primary outcome measure was the development of a major LARS immediately or after stoma closure. In order to identify independent predictors of major LARS, patients were divided into two groups: the "Major LARS" group and the "No Major LARS" group, and then we carried out a descriptive study, followed by an analytical study with logistic regression.
We enrolled 42 patients operated for rectal tumor and had an anterior resection. Half of our patients developed LARS of which 14 developed major LARS. The median time to onset of LARS symptoms was 9 [2 -24] months. At the end of this study, 2 factors were retained: age (OR=2.48; CI95% [1.2- 5.10], p=0.012) and pT3T4 stage (OR=5.95; CI95% [1.07- 33.33], p=0.041) as independent predictive factors of a major LARS. Neoadjuvant therapy was also a risk factor for major LARS in our study with a statistically significant difference (p=0.025) between the two groups "Major LARS" and "No major LARS".
LARS should be appropriately considered in the management of rectal cancer. Based on our results and data from the literature, age and mesorectal invasion were found to be independent predictors of major LARS.
描述直肠前切除术导致的功能预后受损的流行病学和临床数据,并确定主要低位前切除综合征(LARS)的预测因素。
本回顾性研究纳入了 2009 年 1 月 1 日至 2021 年 12 月 31 日期间在我院外科接受直肠肿瘤手术的患者。主要结局指标是在即刻或造口关闭后发生主要 LARS。为了确定主要 LARS 的独立预测因素,将患者分为两组:“主要 LARS”组和“无主要 LARS”组,然后进行描述性研究,随后进行逻辑回归分析。
我们纳入了 42 例接受直肠肿瘤前切除术的患者。我们的一半患者出现了 LARS,其中 14 例出现了主要 LARS。LARS 症状的中位发病时间为 9 [2-24] 个月。在本研究结束时,保留了 2 个因素:年龄(OR=2.48;95%CI[1.2-5.10],p=0.012)和 pT3T4 期(OR=5.95;95%CI[1.07-33.33],p=0.041),是主要 LARS 的独立预测因素。新辅助治疗也是我们研究中主要 LARS 的一个危险因素,两组“主要 LARS”和“无主要 LARS”之间存在统计学差异(p=0.025)。
LARS 应在直肠癌的管理中得到适当考虑。根据我们的结果和文献数据,年龄和中直肠侵犯被发现是主要 LARS 的独立预测因素。